Amgen beats Q3 estimates, shares near 52-week high
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Amgen Inc (AMGN) reported Q3 on Nov 3, 2026, and the numbers were strong. Adjusted EPS was $6.45 against a $5.76 estimate (+11.98%), and revenue was $10.40B against $10.06B. The stock is $478.5 (+3.74%) as of Nov 4, 12:25 PM EST, near its 52-week high of $482.0.…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA fourth straight quarter of EPS above estimates supports shares trading near their 52-week high.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Adjusted EPS was 6.45 dollars against a 5.76 dollar estimate.
- 02Revenue was 10.40 billion dollars against 10.06 billion expected.
- 03Repatha, Evenity and Tezspire posted double-digit growth.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets